AZOLE DERIVATIVE
The present invention provides agents for treating or preventing diseases such as mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disease, drug addiction, epilepsy, cerebral...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; pol |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | YOSHINAGA, MITSUKANE SHIROKAWA, SHIN-ICHI SHIMAZAKI, YOUICHI KUWADA, TAKESHI MIYAKOSHI, NAOKI ISHIZAKA, TOMOKO WAKASUGI, DAISUKE HATTORI, NOBUTAKA |
description | The present invention provides agents for treating or preventing diseases such as mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disease, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injury, inflammation, immune-related disease, alopecia, and so forth. Specifically, the invention provides azole derivatives represented by general formula (I), or pharmaceutically acceptable salts thereof that have an antagonistic action against the arginine-vasopressin (AVP) V1b receptor: |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL2772482TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL2772482TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL2772482TT33</originalsourceid><addsrcrecordid>eNrjZBBwjPL3cVVwcQ3yDHMM8Qxz5WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8QE-RubmRiYWRiEhxsbEqAEAEd8eDw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AZOLE DERIVATIVE</title><source>esp@cenet</source><creator>YOSHINAGA, MITSUKANE ; SHIROKAWA, SHIN-ICHI ; SHIMAZAKI, YOUICHI ; KUWADA, TAKESHI ; MIYAKOSHI, NAOKI ; ISHIZAKA, TOMOKO ; WAKASUGI, DAISUKE ; HATTORI, NOBUTAKA</creator><creatorcontrib>YOSHINAGA, MITSUKANE ; SHIROKAWA, SHIN-ICHI ; SHIMAZAKI, YOUICHI ; KUWADA, TAKESHI ; MIYAKOSHI, NAOKI ; ISHIZAKA, TOMOKO ; WAKASUGI, DAISUKE ; HATTORI, NOBUTAKA</creatorcontrib><description>The present invention provides agents for treating or preventing diseases such as mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disease, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injury, inflammation, immune-related disease, alopecia, and so forth. Specifically, the invention provides azole derivatives represented by general formula (I), or pharmaceutically acceptable salts thereof that have an antagonistic action against the arginine-vasopressin (AVP) V1b receptor:</description><language>eng ; pol</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160831&DB=EPODOC&CC=PL&NR=2772482T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160831&DB=EPODOC&CC=PL&NR=2772482T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YOSHINAGA, MITSUKANE</creatorcontrib><creatorcontrib>SHIROKAWA, SHIN-ICHI</creatorcontrib><creatorcontrib>SHIMAZAKI, YOUICHI</creatorcontrib><creatorcontrib>KUWADA, TAKESHI</creatorcontrib><creatorcontrib>MIYAKOSHI, NAOKI</creatorcontrib><creatorcontrib>ISHIZAKA, TOMOKO</creatorcontrib><creatorcontrib>WAKASUGI, DAISUKE</creatorcontrib><creatorcontrib>HATTORI, NOBUTAKA</creatorcontrib><title>AZOLE DERIVATIVE</title><description>The present invention provides agents for treating or preventing diseases such as mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disease, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injury, inflammation, immune-related disease, alopecia, and so forth. Specifically, the invention provides azole derivatives represented by general formula (I), or pharmaceutically acceptable salts thereof that have an antagonistic action against the arginine-vasopressin (AVP) V1b receptor:</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBBwjPL3cVVwcQ3yDHMM8Qxz5WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8QE-RubmRiYWRiEhxsbEqAEAEd8eDw</recordid><startdate>20160831</startdate><enddate>20160831</enddate><creator>YOSHINAGA, MITSUKANE</creator><creator>SHIROKAWA, SHIN-ICHI</creator><creator>SHIMAZAKI, YOUICHI</creator><creator>KUWADA, TAKESHI</creator><creator>MIYAKOSHI, NAOKI</creator><creator>ISHIZAKA, TOMOKO</creator><creator>WAKASUGI, DAISUKE</creator><creator>HATTORI, NOBUTAKA</creator><scope>EVB</scope></search><sort><creationdate>20160831</creationdate><title>AZOLE DERIVATIVE</title><author>YOSHINAGA, MITSUKANE ; SHIROKAWA, SHIN-ICHI ; SHIMAZAKI, YOUICHI ; KUWADA, TAKESHI ; MIYAKOSHI, NAOKI ; ISHIZAKA, TOMOKO ; WAKASUGI, DAISUKE ; HATTORI, NOBUTAKA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL2772482TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YOSHINAGA, MITSUKANE</creatorcontrib><creatorcontrib>SHIROKAWA, SHIN-ICHI</creatorcontrib><creatorcontrib>SHIMAZAKI, YOUICHI</creatorcontrib><creatorcontrib>KUWADA, TAKESHI</creatorcontrib><creatorcontrib>MIYAKOSHI, NAOKI</creatorcontrib><creatorcontrib>ISHIZAKA, TOMOKO</creatorcontrib><creatorcontrib>WAKASUGI, DAISUKE</creatorcontrib><creatorcontrib>HATTORI, NOBUTAKA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YOSHINAGA, MITSUKANE</au><au>SHIROKAWA, SHIN-ICHI</au><au>SHIMAZAKI, YOUICHI</au><au>KUWADA, TAKESHI</au><au>MIYAKOSHI, NAOKI</au><au>ISHIZAKA, TOMOKO</au><au>WAKASUGI, DAISUKE</au><au>HATTORI, NOBUTAKA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AZOLE DERIVATIVE</title><date>2016-08-31</date><risdate>2016</risdate><abstract>The present invention provides agents for treating or preventing diseases such as mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disease, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injury, inflammation, immune-related disease, alopecia, and so forth. Specifically, the invention provides azole derivatives represented by general formula (I), or pharmaceutically acceptable salts thereof that have an antagonistic action against the arginine-vasopressin (AVP) V1b receptor:</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; pol |
recordid | cdi_epo_espacenet_PL2772482TT3 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | AZOLE DERIVATIVE |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A35%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YOSHINAGA,%20MITSUKANE&rft.date=2016-08-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL2772482TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |